68.5 F
Hobe Sound, FL
Sunday, February 18, 2018


Denver Heart Disease Survivor Recognized by ‘I am CardioSmart’ Contest

2/15/18: For Jared Blitz, exercise has always been the most important part of staying on top of his heart disease. Blitz was born with aortic valve stenosis and had open-heart surgery to replace an aortic valve at the age of 17.

JDRF and Cam Med Partner to Develop Flexible Patch Pump for Automated Insulin Delivery Systems

2/5/18: JDRF, the leading global organization funding type 1 diabetes (T1D) research, and Cam Med LLC, a developer of microfluidic-based drug delivery technologies, announced a new Industry Development and Discovery Partnership today to develop a user-centric insulin pump for next-generation artificial pancreas systems.

Patients Who Achieve Short-Term Weight Loss Before Bariatric Surgery Have Better Outcomes

2/2/18: Patients who lose some excess weight prior to weight loss surgery achieve greater weight loss after surgery, and also experience shorter hospital stays and shorter procedures, according to Journal of American College of Surgeons study findings.

Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, will speak at the 6th Annual World Patient Safety Science & Technology Summit

2/1/18: Global leaders, patient safety experts, hospital and medical technology CEOs and patient advocates will gather to address the challenges that cause medical errors and preventable deaths in hospitals worldwide at the 6th Annual World Patient Safety, Science & Technology Summit in London on February 23-25, 2018. And now, they’ll be joined by the leading voice in global health, the World Health Organization’s (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, who will deliver keynote remarks at the Summit.

‘I am CardioSmart’ Contest Recognizes Oregon Heart Disease Survivor

2/1/18: Michael Melstad was born with a large ventricular septal defect and truncus arteriosus, two congenital heart defects that interfere with the amount of oxygen and blood that reaches the body.

VA Health Insurance Coverage Decisions and Medically Necessary Services Act Helps Patients and Providers

The Health Insurance Coverage Decisions and Medically Necessary Services...

The Optical Society Reports: New Instrument Lets Doctors View the Entire Eye with Unprecedented Level of Detail

1/18/18: Researchers have developed the first instrument that can provide a detailed image of the entire eye. By incorporating a lens that changes optical parameters in response to an electric current, the innovative technology can produce higher quality images than currently available and could make eye examinations faster and more comfortable for patients by avoiding the need to undergo imaging with multiple instruments to look at different areas of the eye.

Study Shows MobileODT Technology Improves Cervical Cancer Detection Rates

1/17/18: Cervical cancer contributes to approximately 6-29% of all cancers in Indian women India accounts for one-quarter of cervical cancer globally 17% of all cancer deaths amongst women in India aged 30-69 are due to cervical cancer EVA System visualisation technology offers potential for early detection of cervical cancers

The AGA Fecal Microbiota Transplantation National Registry Is Officially Underway

HOME AGA announced that the first participant has...

RLI Seeks Nominees for Annual Leadership Luminary Award

1/10/18: The Radiology Leadership Institute® (RLI) is accepting nominations for its 2018 Leadership Luminary Award.

ACR Appropriateness Criteria® Adds and Revises Numerous Topics

HOME Radiologists can enhance the quality and effectiveness...

New Customizable ACR Website Offers More Interactive, Mobile-Friendly Experience

HOME Designed by members, for members, the new...

American College of Cardiology Asia Pacific Conference to Kick Off in Shanghai

11/29/17: The American College of Cardiology will host the ACC Asia Pacific Conference 2017 in Shanghai in collaboration with the China Cardiovascular Association from Dec. 1-3, 2017, bringing together top experts to discuss and review new, relevant cardiovascular science pertinent to the region.

RSNA: MRI Shows Brain Differences Among ADHD Patients

11/22/17: Information from brain MRIs can help identify people with attention deficit hyperactivity disorder (ADHD) and distinguish among subtypes of the condition, according to a study appearing online in the journal Radiology.

Image-Guided, Minimally Invasive Medicine Revolutionizes Emergency Care

11/9/17: Society of Interventional Radiology (SIR), in coordination with Rep. Mia Love, R-Utah, hosted a panel discussion today on the important role of interventional radiologists on trauma teams responding to mass casualty incidents.

ACC President on the 2018 Physician Fee Schedule

HOME American College of Cardiology President Mary Norine...

Innovation Takes Center Stage at 121st Annual Meeting of the American Academy of Ophthalmology

Next week, thousands of eye physicians and surgeons will attend AAO 2017, the American Academy of Ophthalmology's 121st annual meeting.

IDoR 2017: Emergency Radiologists on the Front Lines of Patient Care

HOME Nov. 8 Spotlights International Celebration of Role...


Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview®

2/16/18: Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the indication for Blue Light Cystoscopy (BLC™) with Cysview® to include Flexible Cystoscopes, which are used in the ongoing surveillance of patients with bladder cancer. This is the only combination of drug and device approved for the detection of bladder cancer.

Enovate Medical Introduces Envoy Mobile EHR Workstation

2/15/18: Electronic health record (EHR) workstations have come a long way. Initially just a computer on a cart, today’s EHR workstations are sophisticated clinical tools. Enovate Medical’s new Envoy workstation takes this evolution to the next level. It is the first intelligent workstation designed to reduce nursing fatigue, enhance patient engagement, endure the rigors of hospital settings, and perform without interruption throughout a clinician’s shift.

Study Shows Computer-Guided Insulin Dosing Plus More Frequent Blood Glucose Testing Leads to Better Outcomes for Patients with Diabetes

2/15/18: A retrospective study being presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) observed that use of Glytec’s Glucommander™ Outpatient for insulin therapy management combined with blood glucose self-testing at least twice a day resulted in better patient outcomes, including a 3.0% absolute reduction in A1c and virtually no hypoglycemia (0.003%) less than 54 mg/dL.

RCT Demonstrates a 71% Reduction in the Onset of Sacral Pressure Ulcers When Adding ALLEVYN◊ LIFE to Standard Preventative Protocol

2/15/18: Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the publication of a randomised controlled trial (RCT) demonstrating that the addition of ALLEVYN LIFE, Smith & Nephew’s leading multi-layer silicone adhesive foam dressing, to a standard care protocol significantly reduces the onset of pressure ulcers by 71% in elderly patients admitted to hospital for hip fracture1.

Reduced Time in Hypoglycemia Demonstrated in Tandem Diabetes Care’s Pivotal Trial for the t:slim X2 Insulin Pump with Predictive Low Glucose Suspend Feature; Data to be Presented at ATTD...

2/15/18: Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced positive results from a pivotal study of the t:slim X2™ Insulin Pump with Basal-IQ technology, a predictive low glucose suspend (PLGS) feature. Data showed that the system achieved the primary outcome of reducing time spent in hypoglycemia compared to sensor-augmented pump therapy alone. Details from the study are being presented today at the 11th Annual Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Vienna, Austria by Dr. Bruce Buckingham, Professor of Pediatric Endocrinology at Stanford University, and principal investigator of the PROLOG (PLGS for Reduction Of LOw Glucose) trial.